Market Place
Sourcing Support
All News #Library
Enforcement Report - Week of June 11, 2025
11 Jun 2025 //
FDA
Enforcement Report - Week of February 28, 2024
28 Feb 2024 //
FDA
Enforcement Report - Week of December 6, 2023
06 Dec 2023 //
FDA
Enforcement Report - Week of June 14, 2023
14 Jun 2023 //
FDA
Enforcement Report - Week of May 17, 2023
17 May 2023 //
FDA
Enforcement Report - Week of March 15, 2023
15 Mar 2023 //
FDA
Health Canada Issues Recall of Apotex`s APO-AMITRIPTYLINE 10mg: NDMA Impurity
07 Feb 2023 //
HEALTH CANADA
Enforcement Report - Week of January 4, 2023
04 Jan 2023 //
FDA
Health Canada Issues Recall of Apotex`s Apo-Acyclovir Tablets
28 Jul 2022 //
HEALTH CANADA
Enforcement Report - Week of July 27, 2022
27 Jul 2022 //
FDA
Enforcement Report - Week of May 25, 2022
25 May 2022 //
FDA
Enforcement Report - Week of April 14, 2021
14 Apr 2021 //
FDA
Enforcement Report - Week of February 17, 2021
17 Feb 2021 //
FDA
Enforcement Report - Week of June 24, 2020
24 Jun 2020 //
FDA
Health Canada Issues Recall of Apotex Inc`s APO-Metformin
13 Jun 2020 //
HEALTH CANADA
Enforcement Report - Week of November 20, 2019
20 Nov 2019 //
FDA
Enforcement Report - Week of November 6, 2019
06 Nov 2019 //
FDA
Apotex Corp. Issues Recalls of Drospirenone and Ethinyl Estradiol Tablets
05 Mar 2019 //
FDA
TGA Issues Recall of Mylan Australia`s Dilart and Dilart HCT (valsartan)
25 Nov 2018 //
TGA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.